Background {#Sec1}
==========

*Taenia saginata* is a zoonotic tapeworm that is of economic importance in countries where cattle are kept. The parasite is transmitted from human tapeworm carriers (taeniosis) to bovines (cysticercosis) by excretion of eggs or proglottids containing eggs into the environment *via* the stool. Bovines can then ingest the eggs through contaminated feed or water. After ingestion, the eggs hatch and release oncospheres in the small intestines, where the oncospheres penetrate the intestinal wall to reach the blood circulation. This distributes them throughout the body, but primarily to muscle tissue, where they develop into cysticerci. For humans to become infected with *T. saginata*, raw or undercooked bovine meat or offal containing infective cysts must be consumed. Bovine cysticercosis has been associated with various environmental factors related to water sources, such as animals having access to surface water, flooding of pastures and proximity to wastewater sources \[[@CR1]\].

Taeniosis causes only a few, if any, mild symptoms in humans \[[@CR2]\], and bovine cysticercosis is usually asymptomatic. The primary burden of the parasite is therefore the economic burden imposed on the cattle industry. Economic losses occur when infected carcasses are identified during routine meat inspection at slaughter facilities, causing total economic loss if the carcass is condemned due to high intensity infection, or partial economic loss if extra-processing of the carcass is required due to low intensity infection. Additional costs may include increased labour costs due to extra-handling and transport of infected carcasses to appropriate facilities, in addition to, potential freezing, transport and processing of the meat. However, the current economic burden due to bovine cysticercosis in the Americas has not been estimated.

*Post-mortem* inspection procedures of carcasses for pathogens vary from country to country, and even from facility to facility in some countries. In general, however, this diagnostic method has low sensitivity for detection of bovine cysticercosis \[[@CR3]--[@CR5]\]. Nevertheless, routine meat inspection remains the preferred tool for *T. saginata* detection in bovines. There is currently no *ante-mortem* test that performs with high sensitivity and high specificity, regardless of infection intensity. The sensitivities of existing serological tests are highly dependent on the infection intensity within the host \[[@CR6]\], with the tests becoming increasingly unreliable as infection intensity decreases. The lack of a 'gold standard', combined with the non-specific symptomatic/asymptomatic nature of the diseases caused by the parasite in humans and bovines, and the prolonged survival of *T. saginata* eggs in the environment \[[@CR7]\], makes *T. saginata* difficult to control.

*Taenia saginata* is thought to be widely distributed throughout the world, and to a larger degree in low-income countries where hygiene and sanitation standards are below average and routine meat inspection not always enforced. Nonetheless, in countries where standards of hygiene and sanitation are considered high and routine meat inspection enforced, such as within Europe, bovine cysticercosis still remains widely distributed \[[@CR8]\]. There is no clear overview of the distribution of this zoonotic cestode in the Americas, and with a growing demand for beef, establishing the distribution, prevalence, economic burden, and potentials for control is more important than ever. This paper aims to take the first step, and reviews the distribution of *T. saginata* taeniosis and bovine cysticercosis on a national level within the Americas between 1990 and 2017.

Methods {#Sec2}
=======

Search strategy {#Sec3}
---------------

We undertook a systematic review of published literature for information on the occurrence, prevalence, and geographical distribution of bovine cysticercosis and human taeniosis in the Americas between January 1st, 1990 and December 31st, 2017, using an approach that followed PRISMA guidelines \[[@CR9]\]. The protocol and the PRISMA checklist for this review can be found in Additional file [1](#MOESM1){ref-type="media"}. The Americas for the purpose of this review included the following 54 countries or territories: Anguilla, Antigua & Barbuda, Argentina, Aruba, Bahamas, Barbados, Belize, Bermuda, Bolivia, Brazil, British Virgin Islands, Canada, Caribbean Netherlands, Cayman Islands, Chile, Colombia, Costa Rica, Cuba, Curacao, Dominica, Dominican Republic, Ecuador, El Salvador, Falkland Islands, French Guiana, Greenland, Grenada, Guadeloupe, Guatemala, Guyana, Haiti, Honduras, Jamaica, Martinique, Mexico, Montserrat, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Saint Barthélemy, Saint Kitts & Nevis, Saint Lucia, Saint Martin, Saint Pierre & Miquelon, Saint Vincent & the Grenadines, Suriname, Trinidad & Tobago, Turks & Caicos Islands, Uruguay, US Virgin Islands, USA and Venezuela.

The first search was done in PubMed (<http://www.ncbi.nlm.nih.gov/pubmed>), using the following search phrase: (cysticerc\* OR cisticerc\* OR \"C. bovis\" OR taenia\* OR tenia\* OR saginata OR taeniosis OR teniosis OR taeniasis OR ténia OR taeniid OR cysticerque OR Taeniarhynchus) AND (America OR USA OR Brazil OR Argentina OR Canada OR Peru OR Chile OR Ecuador OR Bolivia OR Paraguay OR Costa Rica OR Uruguay OR Bermuda OR Greenland OR Caribbean Netherlands OR Saint Barts OR Saint Pierre and Miquelon OR Falkland Islands OR Anguilla OR Antigua and Barbuda OR Aruba OR Bahamas OR Barbados OR Belize OR Bonaire OR British Virgin Islands OR Bermuda OR Cayman Islands OR Colombia OR Costa Rica OR Cuba OR Curaçao OR Dominica OR Dominican Republic OR El Salvador OR French Guiana OR Grenada OR Guadeloupe OR Guatemala OR Guyana OR Haiti OR Honduras OR Jamaica OR Martinique OR Mexico OR Montserrat OR Netherlands Antilles OR Nicaragua OR Panama OR Puerto Rico OR Saba OR Saint Kitts and Nevis OR Saint Lucia OR Saint Vincent and the Grenadines OR Saint Eustatius OR Sint Maarten OR Saint Martin OR Suriname OR Trinidad and Tobago OR Turks and Caicos Islands OR US Virgin Islands OR Venezuela). The following databases were also searched using keywords from the above search phrase: Web of Science ([www.webofknowledge.com](http://www.webofknowledge.com)), OpenGrey (<http://www.opengrey.eu/>), and CABDirect (<http://www.cabdirect.org/>).

Selection criteria {#Sec4}
------------------

Outputs from the databases searches were compiled and screened for duplicates. Thereafter, titles and abstracts were screened for eligibility and were excluded on the following grounds: (i) studies concerning a parasite other than *T. saginata*; (ii) studies reporting data from countries different from those listed above; (iii) studies published prior to January 1st, 1990 or after December 31st, 2017; (iv) studies reporting results outside the scope of the review question (e.g. laboratory experiments, environmental studies and general reviews); and (v) duplicated data. If the same data had been published more than once, the oldest article was included and all others omitted. Full text manuscripts were then retrieved where possible and assessed by the same criteria as above (Fig. [1](#Fig1){ref-type="fig"}). The citations in identified reports were also screened for relevant literature.Fig. 1Flow diagram of the database searches

Data on bovine cysticercosis from OIE reports from 1994 to 2005 were also obtained \[[@CR10], [@CR11]\]. Additionally, we sought to obtain data from known articles not captured in the literature database searches, as well as unpublished work (i.e. masters' theses) and these were included if they confirmed presence of *T. saginata* from a country where no disease report had been identified in the literature search, or if prevalence data were presented at a higher geographical resolution to that in the published literature.

Data extraction and generation {#Sec5}
------------------------------

From the included literature and reports, data were extracted into predefined tables that can be found in Additional file [2](#MOESM2){ref-type="media"}: Tables S1-S3. Prevalence data were only extracted if both the numerator and the denominator were provided, and 95% confidence intervals using the Clopper-Pearson method, were calculated, if not already stated within the paper. All maps were generated using ArcGIS 10.3.1 (ESRI Inc., USA).

Results {#Sec6}
=======

Search results {#Sec7}
--------------

The database searches yielded 62 articles presenting data on taeniosis or bovine cysticercosis in the Americas. An additional four articles were identified from other sources and confirmed occurrence of taeniosis in Venezuela, and occurrence of bovine cysticercosis in the USA and the US Virgin Islands. Of the 66 articles identified, 31 reported occurrences of taeniosis, 33 reported occurrences of bovine cysticercosis, and two papers reported occurrences of both diseases. A total of 19 OIE country reports were also identified. All eligible references are listed within the tables of this paper.

Taeniosis and bovine cysticercosis occurrence {#Sec8}
---------------------------------------------

In the period 1990--2017, taeniosis or bovine cysticercosis has been reported within all mainland countries in the Americas except for Belize, French Guiana, Guyana, Panama and Suriname. The only island nations within the region to report any disease occurrence during the study period were Cuba, Haiti and the US Virgin Islands, contributing to occurrence of the parasite in a total of 21 countries within the Americas.

Human taeniosis occurrence {#Sec9}
--------------------------

In the period 1990--2017, taeniosis was reported in 13 countries in the Americas, with *T. saginata* taeniosis reported in nine of those countries (Fig. [2](#Fig2){ref-type="fig"}). Colombia, Haiti, Venezuela and the USA reported taeniosis, but the specific tapeworm species were not confirmed in any of the reports. In seven countries there were reports of bovine cysticercosis, but no reports of taeniosis. In total, 33 papers reporting the occurrence of taeniosis within the Americas were identified in the search strategy. Of the 33 papers, there were three case reports of taeniosis, with species identification done in two of these cases, Chile and Mexico (Table [1](#Tab1){ref-type="table"}). In the case reports from Brazil and Chile, it was unclear exactly when the infection had been discovered.Fig. 2Countries with reports of taeniosis due to *Taenia saginata* and *Taenia* spp. in the period 1990--2017Table 1Individual cases of human taeniosis (published case studies)CountryYearNationalitySpecies^a^Diagnostic techniqueReferenceBrazilnaBrazilian*Taenia* spp.Proglottid identification\[[@CR27]\]Chilenana*T. saginata*Proglottid identification\[[@CR28]\]Mexico2006na*T. saginata*Proglottid identification\[[@CR29]\]*Abbreviation*: *na* information not provided^a^If confirmed

Of the 33 papers, seven contained insufficient data, or the data were of insufficient quality to yield prevalence estimations (Table [2](#Tab2){ref-type="table"}). In the majority of these studies, species identification was performed, but the diagnostic method was not always described.Table 2Aggregated cases of human taeniosis (hospital/laboratory/field records without prevalence data)CountryYearNo. of casesSpecies^a^Diagnostic techniqueReferenceBrazilnana*Taenia* spp.Ritchie technique\[[@CR30]\]Colombia2009--2013na*T. saginata*na\[[@CR31]\]Hondurasna4*T. saginata*Worm expulsion\[[@CR32]\]Peru2004--200716*T. saginata*Worm expulsion\[[@CR33]\]Peru1998--200011*T. saginata*Worm expulsion\[[@CR34]\]Venezuelana1*Taenia* spp.Ritchie technique\[[@CR35]\]Venezuela200418*Taenia* spp.na\[[@CR36]\]*Abbreviation*: *na* information not provided^a^If confirmed

In 23 papers, the methodology and data were sufficiently described to enable prevalence and confidence interval calculations (Table [3](#Tab3){ref-type="table"}). In the majority, disease confirmation was based on various microscopic methods. Prevalence reports ranged from between 0.04--8.8%. All 23 studies reported data that could be georeferenced to first-level administration.Table 3Prevalence of human taeniosis (published data)CountryYearLocation of study^a^Time framePrevalence (%) (95% CI)SpeciesDiagnostic techniqueReferenceArgentina1993CorrientesApr-Oct0.48 (0.01--2.66)*T. saginata* ^b^Microscopy\[[@CR37]\]Argentina2005CorrientesMar-Dec1.77 (0.22--6.25)*Taenia* spp.Graham tests\[[@CR38]\]BrazilnaMinas Geraisna0.18 (0.13--0.26)*Taenia* spp.Kato-Katz\[[@CR39]\]Brazil2000--2001Minas Geraisna0.04 (0.03--0.05)*T. saginata*Worm expulsion\[[@CR40]\]BrazilnaMato Grosso do Sulna2.24 (0.46--6.40)*Taenia* spp.Microscopy\[[@CR41]\]Brazil2004--2006ParanáJun-May0.23 (0.00--0.28)*Taenia* spp.Microscopy\[[@CR42]\]Brazil1992--1993Minas GeraisJan-Dec2.22 (1.43--3.29)*Taenia* spp.Microscopy\[[@CR43]\]Brazil1992Minas Geraisna0.72 (0.46--1.07)*Taenia* spp.Microscopy\[[@CR44]\]Chile2005--2008MauleJan-Dec0.13 (0.07--0.21)*Taenia* spp.Microscopy\[[@CR45]\]Colombia2004BolívarFeb-Jun0.79 (0.16--2.28)*Taenia* spp.Microscopy\[[@CR46]\]Ecuador2000ImbaburaJan-May0.40 (0.13--0.94)*T. saginata*Ritchie technique & worm expulsion\[[@CR47]\]Pichincha2.30 (1.32--3.71)GuatemalanaJutiapana0.06 (0.010.33)*T. saginata*Worm expulsion\[[@CR48]\]Guatemala1991--1995JutiapaOct-Jan0.03 (0.01--0.16)*T. saginata* ^b^Copro-antigen ELISA\[[@CR49]\]Haiti2002Nationwidena0.31 (0.18--0.49)*Taenia* spp.Ritchie technique\[[@CR50]\]HondurasnaFrancisco Morazánna0.25 (0.01--1.37)*Taenia* spp.Ritchie technique\[[@CR51]\]Mexico2004ChihuahuaAug-Dec1.02 (0.21--2.96)*Taenia* spp.Microscopy & Copro-antigen ELISA\[[@CR52]\]Mexico1992Baja CaliforniaFeb-Jul6.5 (2.43--13.66)*Taenia* spp.Microscopy\[[@CR53]\]Mexico1998Guerrerona0.74 (0.15--2.16)*Taenia* spp.Copro-antigen ELISA\[[@CR54]\]Mexico1996Morelosna0.50 (0.10--1.44)*Taenia* spp.Copro-antigen ELISA & Ritchie technique\[[@CR55]\]Peru2008Ayacuchona1.4 (0.44--3.14)*Taenia* spp.Microscopy\[[@CR56]\]PerunaTumbesna1.5 (0.55--3.22)*Taenia* spp.Copro-antigen ELISA\[[@CR57]\]USA2004TexasAug-Dec8.8 (4.11--16.09)*Taenia* spp.Microscopy & Copro-antigen ELISA\[[@CR52]\]VenezuelanaTachirana0.8 (0.02--4.31)*Taenia* spp.Ritchie technique\[[@CR58]\]*Abbreviations*: *CI* confidence interval, *na* information not provided^a^First-level administration^b^No description of species confirmation

Bovine cysticercosis {#Sec10}
--------------------

Bovine cysticercosis was reported from 19 countries within the Americas during the period 1990--2017. The literature search identified nine countries with bovine cysticercosis, and an additional 10 countries were identified through the 1994 and 2005 OIE country reports for notifiable diseases \[[@CR10], [@CR11]\]. *Taenia saginata* was reported from humans in both Guatemala and Peru during 1990--2017, but no reports of bovine cysticercosis could be obtained from these two countries (Fig. [3](#Fig3){ref-type="fig"}). Cuba, Haiti and the US Virgin Islands were the only island nations/territories to report bovine cysticercosis during the study period. On the mainland most countries reported bovine cysticercosis, but no reports could be found from Belize, French Guiana, Guyana, Suriname and Panama. Of the 35 papers identified that reported occurrence of bovine cysticercosis, seven did not contain sufficient data for prevalence calculations. All seven papers reported results of official meat inspections in Brazil, Chile, Cuba, the USA and the US Virgin Islands, respectively (Table [4](#Tab4){ref-type="table"}).Fig. 3Bovine cysticercosis occurrence and countries with studies reporting prevalence in the period 1990--2017Table 4Reported occurrence of bovine cysticercosis (case studies/published data without full prevalence or incidence data) based on meat inspectionCountryYearLocation of study^a^CasesReferenceBrazilnaMinas Geraisna\[[@CR59]\]Brazil2005--2006Goiasna\[[@CR60]\]Brazil2009--2010Minas Gerais2019\[[@CR61]\]Brazil2008--2010Espírito Santona\[[@CR62]\]Chile2010na148\[[@CR63]\]Cuba1998--2001Villa Clarana\[[@CR64]\]USA1985--1994Nationwidena\[[@CR23]\]US Virgin Islands1992nana\[[@CR23]\]*Abbreviation*: *na* information not provided^a^First-level administration

In total, 28 papers contained sufficient information to calculate prevalence and 95% confidence intervals (Table [5](#Tab5){ref-type="table"}). Most of the studies (82%) originated from Brazil, where reported prevalence ranged between 0.1--19%, with both ends of this range obtained by routine meat inspection. Overall, the majority of the studies reported official meat inspection data, but antibody detection (by Ab-ELISA or immunoblot, studies in Brazil) and antigen detection (Ag-ELISA, study in Ecuador) were also used as diagnostic techniques.Table 5Prevalence of bovine cysticercosis (published data)CountryYearLocation of study^a^Time framePrevalence (95% CI)Diagnostic techniqueReferenceBrazil2013Minas GeraisJan-Jun2.1 (2.01--2.22)Meat inspection\[[@CR65]\]Brazil2006--2007Bahiana0.7 (0.64--0.67)Meat inspection\[[@CR66]\]Brazil2004Minas Geraisna3.2 (3.00--3.48)Meat inspection\[[@CR67]\]BrazilnaMato Grosso do Sulna18.8 (11.51--28.00)Meat inspection\[[@CR68]\]Brazil2000ParanáJul-Dec3.8 (3.60--4.07)Meat inspection\[[@CR69]\]Brazil2013Minas GeraisJul-Aug15.1 (12.91--17.44)Ab-ELISA\[[@CR70]\]4.7 (3.47--6.19)ImmunoblotBrazil2007--2010NationwideJan-Apr1.1 (1.05--1.05)Meat inspection\[[@CR71]\]Brazil2010--2015NationwideJan-Dec0.6 (0.62--0.62)Meat inspection\[[@CR72]\]Brazil2004ParanáJan-Dec9.3 (6.57--12.58)Meat inspection\[[@CR73]\]Brazil2010--2011São PauloOct-Aug4.8 (4.58--5.04)Meat inspection\[[@CR74]\]Brazil2003--2004Rio de JaneiroJan-Dec2.3 (2.07--2.45)Meat inspection\[[@CR75]\]BrazilnaMinas Geraisna10.6 (7.55--14.40)Ab-ELISA\[[@CR76]\]4.1 (2.28--6.83)ImmunoblotBrazil2004--2008ParanáJan-Dec2.2 (2.22--2.24)Meat inspection\[[@CR77]\]Brazil1997--2003Rio de JaneiroJan-Dec2.0 (1.91--1.99)Meat inspection\[[@CR78]\]Brazil2012São PauloJan-Dec2.9 (2.83--3.03)Meat inspection\[[@CR79]\]Minas Gerais1.8 (1.71--1.93)Goias0.7 (0.61--0.82)Mato Grosso do Sul1.1 (0.77--1.58)Brazil2013--2014Mato GrossoJan-Dec0.1 (0.09--0.09)Meat inspection\[[@CR80]\]Brazil2009Minas Geraisna2.5 (0.92--5.36)Ab-ELISA\[[@CR81]\]Brazil2009--2010BahiaJan-Jan3.6 (3.43--3.69)Meat inspection\[[@CR82]\]Brazil2008GoiásJan-Dec0.7 (0.67--0.73)Meat inspection\[[@CR83]\]Brazil2000ParanaJul-Dec3.8 (3.60--4.07)Meat inspection\[[@CR84]\]Brazil2009--2013Rio Grande do SulJan-Dec2.5 (2.28--2.78)Meat inspection\[[@CR85]\]Brazil2011--2013Rio Grande do Sul & TocantinsJan-Apr5.0 (2.80--8.03)Meat inspection\[[@CR86]\]BrazilnaParaíbana2.7 (2.11--3.46)Ab-ELISA\[[@CR87]\]Canada1992OntarioOct; Dec5.8 (4.81--6.82)Meat inspection\[[@CR88]\]Canada2000AlbertaApr7.9 (4.02--13.72)Meat inspection\[[@CR89]\]Ecuador2000--2001Imbabura; PichinchaDec-Jan5.8 (3.71--8.57)Ag-ELISA\[[@CR47]\]0.3 (0.01--1.48)Meat inspection2.5 (1.32--4.40)Ag-ELISA0.5 (0.06--1.66)Meat inspectionMexico2008--2009NationwideOct-Jul0.2 (0.17--0.25)Meat inspection\[[@CR90]\]USA1992--1993IdahoMay-May8.9 (8.09--9.66)Meat inspection\[[@CR91]\]*Abbreviations*: *CI* confidence interval, *na* information not provided^a^First-level administration

Brazil was the only country, where data on bovine cysticercosis could be obtained from several regions of the country. In the period 1990--2017, bovine cysticercosis was reported in 70% (19/27) of the states (first-level administration) in Brazil. As an illustration of risk of bovine cysticercosis, Fig. [4](#Fig4){ref-type="fig"} shows the 2006 modelled density of cattle in Brazil \[[@CR12]\], overlaid with the 19 states from where bovine cysticercosis was reported during 1990--2017.Fig. 4States in Brazil with bovine cysticercosis during 1990--2017 and the modelled cattle density for Brazil in 2006 \[[@CR12]\]

Discussion {#Sec11}
==========

This review shows that *T. saginata* is widely distributed across the Americas. Taeniosis was widely reported, but not always at the species level. The estimation of the distribution and the prevalence of taeniosis is severely complicated by the lack of specific symptoms in tapeworm carriers \[[@CR2]\], and the fact that the disease is not commonly notifiable. Some studies differentiated between *T. saginata* taeniosis and the much more dangerous infection, *T. solium* taeniosis. This was usually done in studies with a research objective where the study outcome was dependent on the species differentiation. In health care and routine screening, this information is seen to be of less importance to the physicians attending as the anthelminthic treatments prescribed to patients will be effective against either parasite species \[[@CR13], [@CR14]\], despite the risk of cysticercosis transmission to either the carrier or their family members if *T. solium* is present.

The majority of the taeniosis infections reported had been identified by microscopic examination for the presence of *Taenia* spp. eggs, which has low sensitivity \[[@CR15]\], and cannot be used for determining the diagnosis to species level. Prevalence of taeniosis ranged from very low levels to almost 9%, which is very similar to previous reports of taeniosis prevalence (0.01--10%) from Europe \[[@CR16]\]. However, a direct comparison between studies is not appropriate, as variables such as study duration, recruitment criteria, diagnostic methods and standards of randomisation differ across studies. Clinical investigators should be encouraged to adopt a consensus protocol for collecting and analysing data for apparent taeniosis prevalence estimation, which would make comparison between studies and areas less biased.

It is clear from this review that bovine cysticercosis is widely distributed across the mainland of the Americas. It also indicates, however, a scarcity of recent data from the region. *Taenia saginata* taeniosis was reported from both Guatemala and Peru, but we were unable to identify any reports of bovine cysticercosis from either country. More than half of countries found to have bovine cysticercosis were found through the OIE databases \[[@CR10], [@CR11]\]. However, bovine cysticercosis is no longer notifiable to the OIE, and the reporting, if any, is not standardised across the countries in the region. The occurrence of bovine cysticercosis could only be georeferenced to a first-level administration in five countries. This illustrates that for most of the countries where *T. saginata* is endemic, more data are needed to pinpoint areas of risk and areas with high transmission rates. Presence of bovine cysticercosis seems to be related to the number of animals within a farm \[[@CR17]\], spatial modelling of livestock density could therefore be considered as a first step in estimating areas of risk, such as previously done for *T. solium* \[[@CR18]\]. Detailed mapping studies with prevalence of bovine cysticercosis are warranted for all endemic countries; however, such studies only seem to have been performed in Brazil. Bovine cysticercosis prevalence based on meat inspection ranged from very low levels to almost 19%, which is a higher range than recent reports from Europe (\< 5%) \[[@CR8]\], the Middle East (3%) \[[@CR19]\] and Africa (\< 4%) \[[@CR20], [@CR21]\].

Only five countries on the mainland (Belize, French Guiana, Guyana, Suriname and Panama) did not have reports of taeniosis or bovine cysticercosis. All five countries have cattle industries and in 2016 had an estimated number of cattle: 110,024 in Belize, 18,945 in French Guiana, 10,115 in Guyana, 36,138 in Suriname, and 1,554,200 in Panama \[[@CR22]\]. Due to reports of bovine cysticercosis from neighbouring countries, the missing reports could be a result of underreporting rather than absence of the parasite in these populations. Epidemiological surveys should be performed in these five countries in order to confirm or refute the absence of *T. saginata*. The lack of reports of *T. saginata* from the smaller Caribbean islands, except for one case from the US Virgin Islands in 1994 \[[@CR23]\], could suggest that infection pressure is insufficient to sustain transmission on these islands and reports are a result of small self-limiting outbreaks resulting from imported taeniosis cases. Cattle populations are relatively small on the Caribbean islands with many islands slaughtering less than 1000 cattle annually \[[@CR22]\], which would likely mitigate any potential outbreak to burn out quickly. However, bovine cysticercosis was found on the two largest Caribbean islands (Cuba and Hispaniola). On Hispaniola, bovine cysticercosis was only reported in Haiti (Fig. [4](#Fig4){ref-type="fig"}); thus, investigations to explore the situation in the Dominican Republic are highly warranted.

There are clear diagnostic issues in terms of both taeniosis and bovine cysticercosis. The sensitivity of meat inspection for bovine cysticercosis can be increased to some extent by making more incisions into organs and muscles of the carcass. However, the risk of contaminating the carcass with microbes that pose a risk to food safety is correlated with the number of incisions made \[[@CR24]\]. Since the health risk in *T. saginata* infections are minimal, compared to those of bacterial pathogens for example, an increase of the number of incisions might be unwise or should perhaps be completely avoided under certain circumstances. However, more incisions in the heart has been shown to increase the sensitivity for the diagnosis of bovine cysticercosis compared to the EU-approved routine meat inspection \[[@CR25]\]. Still, more research is required to determine whether meat inspection procedures should be changed and what consequences it will have for areas of low and high bovine cysticercosis endemicity, respectively. Another approach to reduce transmission risk could be risk-based meat inspection in countries where appropriate herd level data is obtainable \[[@CR26]\].

*Taenia saginata* is prevalent in countries where sanitation standards are high \[[@CR8]\], suggesting that elimination of this parasite is extremely difficult. Epidemiological surveys and mapping studies should be performed in all endemic countries in order to evaluate the distribution and the economic burden of *T. saginata* and to assess whether cost-effective intervention measures can be implemented. Standard goals should be put forward in terms of describing a protocol for estimating the distribution, prevalence, incidence and the economic burden of bovine cysticercosis. Based on the economic analyses, cost-effective measures can then be implemented, if appropriate, in the efforts to control *T. saginata*.

Conclusions {#Sec12}
===========

*Taenia saginata* is widely distributed across the Americas, but the epidemiological data available are insufficient to estimate the subnational spatial distribution, prevalence, incidence and intensity of infections. This needs to be addressed through active surveillance and disease detection programmes. Such programmes would ameliorate the lack of data needed to quantify the economic burden bovine cysticercosis imposes on the region. These issues should be addressed in order to assess the need and advocate for implementation of cost-effective control measures against *T. saginata* if necessary.
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